Health Condition 1: O- Medical and Surgical Health Condition 2: S529- Unspecified fracture of forearm
Conditions
Interventions
Intervention1: Nalbuphine 5 mg with Bupivacaine: Compare efficacy of Nalbuphine 5 mg with Bupivacaine in Brachial plexus block
Control Intervention1: Nalbuphine 10 mg with Bupivacaine: Compare efficac
Sponsors
Heritage Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Eligible age group for study 18-65 years old of weight 50-90 kg. Eligible gender for study Both Male and Female ASA physical status classification I-II Patients scheduled for elective upper limb surgery
Exclusion criteria
Exclusion criteria: Patients denying consent for study. Diabetic neuropathy. Known nerve injury in the upper limb posted for surgery. Known contraindications to regional anaesthetic techniques as coagulopathy. ASA physical status class III-IV. Skin infection at site of anaesthesia. Known hypersensitivity to the drugs used in studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of Nalbuphine 5mg vs Nalbuphine 10mg as an adjuvant in brachial plexus blockTimepoint: immediately after injection,5 Min,10 Min | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess post operative duration of analgesia(using NRS score)Timepoint: immediately after surgery,At an interval of 2 hours after surgery | — |
Countries
India
Contacts
Public ContactLt Gen RDS Ahluwalia retd VSM
Heritage institute of medical sciences
Outcome results
None listed